scholarly article | Q13442814 |
P356 | DOI | 10.1161/HYPERTENSIONAHA.111.00157 |
P8608 | Fatcat ID | release_sbesnltdpzcxlf5q7nsq3paqxq |
P932 | PMC publication ID | 4131732 |
P698 | PubMed publication ID | 23283357 |
P2093 | author name string | Wei Wang | |
Yang Xia | |||
Rodney E Kellems | |||
Weiru Zhang | |||
Roxanna A Irani | |||
Sean C Blackwell | |||
Athar H Siddiqui | |||
P2860 | cites work | Expression of vascular endothelial growth factor and its receptors Flk-1 and Flt-1 during the regeneration of autotransplanted adrenal cortex in the adrenalectomized rat. | Q40512636 |
New insights into the etiology of pre-eclampsia | Q40826375 | ||
Actions of placental and fetal adrenal steroid hormones in primate pregnancy | Q40928049 | ||
Progesterone and estradiol production by normal and preeclamptic placentas | Q43999690 | ||
Angiogenesis in human normal and pathologic adrenal cortex | Q44203985 | ||
Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH. | Q44251620 | ||
Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repair | Q44576212 | ||
Vascular patterns in the normal and pathological human adrenal cortex | Q47733926 | ||
Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome. | Q50872637 | ||
Analysis of changes in the renin-angiotensin system during pregnancy | Q68640705 | ||
Paracrine control of the adult adrenal cortex vasculature by vascular endothelial growth factor | Q73483552 | ||
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia | Q74195115 | ||
VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors | Q78686370 | ||
Explaining and predicting preeclampsia | Q80223255 | ||
Pre-eclampsia | Q81446389 | ||
Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia | Q28244090 | ||
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
The renin-aldosterone system during normal and hypertensive pregnancy | Q32015886 | ||
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension | Q33666742 | ||
Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice | Q35683468 | ||
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
Renin angiotensin signaling in normal pregnancy and preeclampsia | Q35743816 | ||
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology | Q35776377 | ||
Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors | Q35789199 | ||
Preeclampsia: a renal perspective | Q36120940 | ||
Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
Role of aldosterone availability in preeclampsia | Q36826506 | ||
Pathogenesis of preeclampsia | Q37676212 | ||
Regulation of placental growth by aldosterone and cortisol | Q39633468 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoantibody | Q785022 |
pre-eclampsia | Q61335 | ||
P304 | page(s) | 472-479 | |
P577 | publication date | 2013-01-02 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia | |
P478 | volume | 61 |
Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
Q38118625 | Activating autoantibodies and cardiovascular disease |
Q47799852 | Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy |
Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
Q28083815 | Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia |
Q46252084 | Combined Effects of Gestational Phthalate Exposure and Zinc Deficiency on Steroid Metabolism and Growth |
Q38543831 | Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia? |
Q47581048 | Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca(2+) overload in H295R cells |
Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
Q58130020 | Physiological and Molecular Responses to Altered Sodium Intake in Rat Pregnancy |
Q54119733 | Placental Growth Factor Reverses Decreased Vascular and Uteroplacental MMP-2 and -9 and increased MMP-1 and -7 and Collagen I and IV in Hypertensive Pregnancy. |
Q26752442 | Recent advances in central cardiovascular control: sex, ROS, gas and inflammation |
Q42356968 | Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy |
Q37206448 | The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies |
Q38176651 | The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad. |
Search more.